AUP.TO
Aurinia Pharmaceuticals Inc
Price:  
16.76 
CAD
Volume:  
137,920.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AUP.TO EV/EBITDA

-
Upside

As of 2024-07-22, the EV/EBITDA ratio of Aurinia Pharmaceuticals Inc (AUP.TO) is -15.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AUP.TO's latest enterprise value is 1,934.37 mil CAD. AUP.TO's TTM EBITDA according to its financial statements is -126.05 mil CAD. Dividing these 2 quantities gives us the above AUP.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
16.76 CAD
Stock Price
- CAD
Fair Price

AUP.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA